Sino Biopharmaceutical Limited: all 470 studies

Page 1 of 5. Open to participants first (164), then studies with results posted, then the rest; newest registration first within each.

• A Phase 2a Study of Kylo-0603 Capsule in Participants With Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)Not yet recruitingNCT07878091Phase 2
• A Phase I/II of LM-364 as a Single Agent or in Combination With Anti-tumor Therapy in Patients With Advanced Solid TumorsNot yet recruitingNCT07847905Phase 1/2
• TQB2922 Injection Given Under the Skin With Chemotherapy as Initial Treatment for Colorectal Cancer That Has SpreadNot yet recruitingNCT07844187Phase 1/2
• A Clinical Trial of TQF3250 Capsules in Overweight/Obese Trial Participants With Poor Weight Control Through Simple Lifestyle InterventionRecruitingNCT07798284Phase 1
• Clinical Trial of TQA3605 Tablet in Combination With Nucleos(t)Ide Analogues(NAs) Versus NAs Alone for the Treatment of Patients With Chronic Hepatitis B Virus Infection Who Have Undergone Treatment and Exhibit Low Viral Load or Poor ResponseNot yet recruitingNCT07797231Phase 3
• A Clinical Trial of TQF6422 Injection in Overweight or Obese Healthy Subjects.Not yet recruitingNCT07794111Phase 1
• A Clinical Trial to Evaluate the Efficacy and Safety of TQB3909 Tablets Versus Investigator's Choice in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)Not yet recruitingNCT07753369Phase 3
• A Clinical Trial Evaluating TQF3250 Capsules in Patients With Type 2 Diabetes Mellitus and Overweight/ObesityRecruitingNCT07747857Phase 1
• Clinical Trial Evaluating the Efficacy and Safety of TQB3454 Tablets in Participants With Advanced Solid TumorsNot yet recruitingNCT07738679Phase 2
• A Clinical Trial of TQB6426 for Injection in Patients With Advanced Solid TumorsRecruitingNCT07730190Phase 1
• A Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque PsoriasisRecruitingNCT07724366Phase 3
• Clinical Trial of TQB3126 for Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Breast Cancer SubjectsRecruitingNCT07697443Phase 1/2
• A Study of LM-364 as a Single Agent or in Combination With Anti-tumor Therapy in Patients With Advanced Solid TumorsNot yet recruitingNCT07694765Phase 1/2
• A Study of LM-168 Combined With Other Anti-tumor Treatments in Participants With Advanced Solid TumorsRecruitingNCT07669415Phase 2
• Treatment of Chinese Adult Subjects With Moderate to Severe Crohn's Disease With Tabellvi®RecruitingNCT07663526Phase 4
• A Multicenter, Open-label Study on the Efficacy and Safety of Tebiovio® (Adalimumab) in Treating Chinese Children With Severe Plaque PsoriasisRecruitingNCT07663331Phase 4
• A Clinical Trial Evaluating TQB2930 Injection and Chemotherapy With or Without Bevacizumab in Patients With HER2-Abnormally Expressed Unresectable Locally Advanced or Metastatic Colorectal Cancer.RecruitingNCT07653685Phase 1/2
• Treatment of Recurrent/Metastatic Head and Neck CancerNot yet recruitingNCT07601204Phase 1/2
• Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple MyelomaNot yet recruitingNCT07569757Phase 3
• A Clinical Trial of Taibowei® Adalimumab Injection in the Treatment of Chinese Pediatric Patients With Moderately to Severely Active Crohn's DiseaseRecruitingNCT07564505Phase 4
• A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of TQ05105 Tablets in Subjects With Intermediate/High-risk MyelofibrosisRecruitingNCT07551427Phase 2
• Clinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced or Unresectable Alveolar Soft Part SarcomaRecruitingNCT07548177Phase 2
• Efficacy and Safety of TRD205 Tablets for Postoperative Analgesia in Unilateral Total Hip Arthroplasty (Phase IIb)RecruitingNCT07543796Phase 2
• A Clinical Study to Evaluate the Pharmacokinetics and Safety of Anecatibin Fumarate Capsules in Subjects With Impaired Liver Function Versus Normal Liver FunctionNot yet recruitingNCT07538973Phase 1
• A Clinical Trail of Adalimumab in Treating Chinese Children With Severe Plaque PsoriasisNot yet recruitingNCT07529925Phase 4
• Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative BacteriaRecruitingNCT07512596Phase 2
• Clinical Studies of TQB2930 Injection for the Treatment of Advanced Solid TumorsRecruitingNCT07512583Phase 1/2
• A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus ErythematosusRecruitingNCT07509892Phase 2
• A Clinical Study to Evaluate Injection TQB2102 for the Treatment of Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Progressed After Treatment With Oxaliplatin, Irinotecan and Fluoropyrimidine-Based DrugsNot yet recruitingNCT07483684Phase 3
• Clinical Trial of TQB3205 Capsule in Subjects With Advanced Malignant TumorsRecruitingNCT07482592Phase 1
• To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Hepatic Impairment SubjectsRecruitingNCT07480824Phase 1
• A Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)RecruitingNCT07464912Phase 3
• Evaluation of the Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseRecruitingNCT07464587Phase 3
• An Efficacy and Safety Study of NTB003 in Participants With Thyroid Eye Disease (TED)Not yet recruitingNCT07462130Phase 1/2
• Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform NeurofibromasRecruitingNCT07407803Phase 3
• A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic ArthritisRecruitingNCT07406035Phase 2
• Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic RhinitisRecruitingNCT07398859Phase 2
• A Phase III Clinical Trial of NTQ1062 in Combination With Fulvestrant for the Treatment of Advanced or Metastatic HR+/HER2- Breast CancerNot yet recruitingNCT07393321Phase 3
• Phase II Study of LM-24C5RecruitingNCT07387081Phase 2
• Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.RecruitingNCT07385703Phase 3
• An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid TumorsRecruitingNCT07371663Phase 1/2
• A Clinical Trial on the Efficacy and Safety of TQB6411 for InjectionRecruitingNCT07367529Phase 1/2
• Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal CancerRecruitingNCT07367516Phase 1/2
• LM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of Subjects With CCR8-Positive Gastric and Gastroesophageal Junction AdenocarcinomaRecruitingNCT07362186Phase 3
• To Evaluate the Tolerability and Pharmacokinetics of TQB3142 for Injection in Patients With Advanced Malignant TumorsRecruitingNCT07338838Phase 1
• A Clinical Trial Evaluating TQF3250 Capsules in Healthy Adult SubjectsRecruitingNCT07327281Phase 1
• Phase I Study of CPD704 Inhalation Suspension in Healthy SubjectsRecruitingNCT07301203Phase 1
• A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3217 Tablets in Subjects With Advanced Malignant TumorsNot yet recruitingNCT07291050Phase 1
• A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3122 Capsules in Subjects With Advanced Malignant TumorsRecruitingNCT07269145Phase 1
• Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis PatientsRecruitingNCT07266116Phase 1/2
• Clinical Trial of TQB2922 Injection (Subcutaneous Injection) in Patients With Advanced CancersRecruitingNCT07260708Phase 1
• Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular LymphomaNot yet recruitingNCT07187960Phase 3
• Phase I Clinical Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics of NTB003 in Healthy ParticipantsEnrolling by invitationNCT07182552Phase 1
• A Clinical Study Assessing the Subcutaneous Formulation of TQB2934 for Injection in Subjects With Malignant Plasma Cell TumorsRecruitingNCT07179679Phase 1
• A Long-term Efficacy and Safety of NTQ5082 CapsulesNot yet recruitingNCT07177872Phase 3
• A Phase III Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria PatientsNot yet recruitingNCT07177859Phase 3
• Clinical Trial to Evaluate the Tolerance of TQB3201 TabletsNot yet recruitingNCT07172126Phase 1/2
• Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)RecruitingNCT07165951Phase 3
• Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseNot yet recruitingNCT07147946Phase 3
• FHND1002 for ALS Treatment: Phase 2Not yet recruitingNCT07138014Phase 2
• To Evaluate the Efficacy and Safety of TRD205 Tablets in the Treatment of Chronic Postoperative NeuralgiaEnrolling by invitationNCT07123402Phase 2
• To Evaluate the Safety, Efficacy and Kinetic Characteristics of TRD205 Tablets for Postoperative Analgesia After Unilateral Hip ArthroplastyNot yet recruitingNCT07121101Phase 2
• To Evaluate the Safety, Efficacy and Kinetic Characteristics of TRD205 Tablets for Postoperative Analgesia After Unilateral Hallux Valgus Orthopedic SurgeryNot yet recruitingNCT07121023Phase 1
• A Clinical Trial Evaluating TQB2101 in Subjects With Advanced Hematologic MalignanciesRecruitingNCT07113925Phase 1
• A Study of LM-350 in Subjects With Advanced Solid TumoursRecruitingNCT07112222Phase 1/2
• Phase I Clinical Trial of TQB2825 Subcutaneous Injection in CD20-positive Hematological MalignanciesNot yet recruitingNCT07110194Phase 1
• Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal PolypsRecruitingNCT07107256Phase 3
• A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in AdultsNot yet recruitingNCT07083739Phase 2
• TQB2930 Injection for the Treatment of HER2-positive Advanced Breast CancerRecruitingNCT07047365Phase 3
• TQB2922 and TAS-102 Tablets for Injection With or Without Bevacizumab in Chemotherapy-failed RAS/BRAF Wild-type Advanced Colorectal CancerRecruitingNCT07044908Phase 1/2
• A Clinical Trial Evaluating Injection of TQB6411 in Subjects With Advanced Malignant TumorsRecruitingNCT07043751Phase 1
• A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast CancerRecruitingNCT07043725Phase 3
• A Clinical Trial of TQB3909 Tablets in Combination With Azacitidine for the Treatment of Myeloid MalignanciesRecruitingNCT07011186Phase 1/2
• Clinical Trial of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in HER2-positive Advanced Breast CancerRecruitingNCT07008976Phase 3
• A Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of HER2 Positive Recurrent or Metastatic Breast CancerRecruitingNCT07003074Phase 3
• Evaluate the Efficacy and Safety of NTQ5082 Capsules in Patients With Primary IgA NephropathyNot yet recruitingNCT06982040Phase 2
• Clinical Study on the Effectiveness and Safety of Succinylated Gelatin InjectionNot yet recruitingNCT06977763Not applicable
• Clinical Study on the Effectiveness and Safety of Succinylated Gelatin Electrolyte Sodium Acetate InjectionRecruitingNCT06977750Not applicable
• A Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916 Injection Combined With Gemcitabine Hydrochloride for Injection and Paclitaxel for Injection (Albumin-bound Type)RecruitingNCT06962267Phase 2
• To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant TumorsNot yet recruitingNCT06948539Phase 1
• A Clinical Trial on the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TQB3019 Capsule in Subjects With Advanced Malignant TumorsRecruitingNCT06943677Phase 1
• A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune ThrombocytopeniaRecruitingNCT06900920Phase 3
• A Study of LM-108 in Combination With Toripalimab in Subjects With Advanced Solid TumoursNot yet recruitingNCT06873854Phase 2
• A Study of LM-168 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid TumoursRecruitingNCT06868199Phase 1/2
• A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid CarcinomaRecruitingNCT06860971Phase 3
• Clinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE)Not yet recruitingNCT06859931Phase 2
• Clinical Trial of TQB2825 Injection Combined With Chemotherapy in Subjects With Diffuse Large B-cell LymphomaRecruitingNCT06854445Phase 2
• TQC2731 Clinical Trial for the Treatment of Severe Asthma With InjectionRecruitingNCT06829784Phase 3
• Clinical Trial of TQB2825 Injection Combined Immunochemotherapy in Subjects With Diffuse Large B Cell LymphomaRecruitingNCT06829771Phase 1/2
• Clinical Studies for the Treatment of Advanced Solid TumorsRecruitingNCT06825494Phase 1/2
• Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort CRecruitingNCT06821503Phase 1/2
• A Clinical Trial of TQB2102 for Injection in Gynecological Tumors With Recurrent/Metastatic AdvancedRecruitingNCT06798207Phase 2
• Safety, Tolerability, and Pharmacokinetics of FHND1002 Granules in Healthy AdultsEnrolling by invitationNCT06782958Phase 1
• Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic NeoplasmsRecruitingNCT06767813Phase 2
• A Clinical Trial Evaluating TQB2102 for Injection in Combination With Behmosubaisumab/Payamprolizumab With or Without Chemotherapy in Unresectable Locally Advanced, Recurrent, or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastroesophageal AdenocarcinomaRecruitingNCT06767800Phase 2
• Bioequivalence Study of Two Brivaracetam Oral Solutions in Healthy Adults Under Fasting and High-Fat Meal ConditionsEnrolling by invitationNCT06762743Phase 1
• FHND9041 Versus Afatinib for Non-small Cell Lung CancerEnrolling by invitationNCT06759857Phase 3
• Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's DiseaseRecruitingNCT06754891Phase 1
• A Clinical Study of TQB2029 for Injection in Subjects With Multiple MyelomaRecruitingNCT06700395Phase 1
• A Phase I/II Study of LM-2417 in Subjects With Advanced Solid TumoursRecruitingNCT06682780Phase 1/2

← Sino Biopharmaceutical Limited overview and focus areas